537 related articles for article (PubMed ID: 29178624)
1. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
3. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
[TBL] [Abstract][Full Text] [Related]
4. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
8. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
10. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum with multiple malignancies.
Nalgirkar AR; Borkar SS; Nalgirkar SA
Indian Pediatr; 2000 Dec; 37(12):1377-9. PubMed ID: 11119344
[No Abstract] [Full Text] [Related]
13. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.
Ben Rekaya M; Naouali C; Messaoud O; Jones M; Bouyacoub Y; Nagara M; Pippucci T; Jmel H; Chargui M; Jerbi M; Alibi M; Dallali H; Bashamboo A; McElreavey K; Romeo G; Barakat A; Zghal M; Yacoub-Youssef H; Abdelhak S
J Dermatol Sci; 2018 Feb; 89(2):172-180. PubMed ID: 29169765
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
16. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
[TBL] [Abstract][Full Text] [Related]
19. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
20. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
